seminar on magnetic microspheres presented by ushasri department of industrial pharmacy university...

37
Seminar on MAGNETIC MICROSPHERES Presented by Ushasri

Upload: leo-anderson

Post on 22-Dec-2015

217 views

Category:

Documents


2 download

TRANSCRIPT

Seminar on

MAGNETIC MICROSPHERES

Presented by

Ushasri

Department of Industrial pharmacyUniversity college of pharmaceutical sciences

KAKATIYA UNIVERSITY

CONTENTS

INTRODUCTION

DEFINITION

RATIONALE OF THE DRUG DELIVERY SYSTEM

ADVANTAGES AND DISADVANTAGES

PRINCIPLE OF MAGNETIC DRUG TARGETING

FORMULATION

PREPARATION OF MAGNETIC MICROSPHERES

CHARACTERIZATION

APPLICATIONS

CONCLUSION

REFERENCES

INTRODUCTION Drug targeting:Delivery of drugs to receptors or organ or any other specific part of

the body exclusively.

Various nonmagnetic micro carriers are utilized for drug targeting but they show poor site specificity and are rapidly cleared off by RES .

Magnetic particles composed of magnetite are well tolerated by body. Magnetic fields are believed to be harmless to biological systems and adaptable to

any part of the body.

Up to 60% of injected dose deposited and released in a controlled manner .

Magnetic micro carriers were developed to overcome two major problems encountered in drug targeting

RES clearance Target site specificity.

DEFINITION:

Magnetic microspheres are spherical particles, composed of metallic iron and activated carbon which serves as a delivery vehicle for the site specific targeting, retention and release of pharmaceuticals.

It utilizes the physical force of magnetic field for the targeted delivery of pharmaceutical agents to specific areas of the body.

Size range -1-100µm. ROA: IV –NLT(5µm)

Intra arterial-NLT(1ooµm).

The physical force created by the magnetic field draw the magnetic targeted carrier drug compound through the arteriole wall in to the targeted disease area. This process is known as extra vasation.

Results in localization and retention of the delivered pharmaceutical agents at the delivered site even when the magnetic field has been removed.

This technology uses a small externally positioned magnet to create a localized magnetic field within the body.

Rationale of thE delivery system

Number of problems exists for successful targeting of biodegradable carriers

1. Rapid sequestration of IV administered drug carriers by mono nuclear phagocytes of the RES.

Approaches to over come

By blocking RES prior to administering the drug carrier

Impart specificity to the drug carrier by incorporating the specific ligand on external surface of the carrier.

2. Vascular system

The endothelial cell lining the capillary level vasculature have severely

frustrated attempt at invivo targeting

And shield the carrier from recognization

In order to circumvent the RES and provide a method of site specific drug

delivery a magnetically responsive drug carrier was developed.

Retention of magnetic carrier at target site

will delay RES clearance

facilitate extravasation

prolong the systemic action of the drug .

ADVANTAGES

Reduces circulating concentration of free drug .

Minimizes damage to the normal tissue cells and allows an effective treatment of

regioned disease.

Delivers 60% of the dose to target tissues.

Making the drug available in controlled fashion within the tissue.

Advantage of crossing microvascular barriers .

Minimally reactive with blood components.

Clinically nontoxic from the stand points of chemical and immunological agents.

Capable of accommodating a wide variety of water soluble agents.

Magnetite is readily available from the commercial sources, individual particles are

much smaller (10-20mm) occupy a fraction of the drug space.

DISADVANTAGES

Requires specialized microspheres and magnets .

Treatment of multiple region requires sequential targeting.

Demands new methods for noninvasive , localized monitoring term deposition

of drug levels in target tissues.

Expensive.

Tissue localization of microspheres result long term deposition of magnetite at

levels of 3.5mg/kg.

Once the drug is released it is no longer attractive to the magnetic field .

Possibility of embolisation of the blood vessels due to accumulation of magnetic

carriers.

Drug

/Carrier

Circulation

Target tissue

Little

access

RES ORGANSLiver/Spleen Phagocytosis

Major pathway

PRINCIPLE OF MAGNETIC DRUG TARGETING

Magnetic carrier

Circulation

RES organs (liver,spleen,bonemarrow

Target tissue

Major pathway

Little access

FORMULATION OF MAGNETIC MICROSPHERES

Components

Matrix:

It comprises cross linkable material that will cross link upon heating .

The matrix material forms the bulk micro particle structure in which the agent is

dispersed orencapsulated.

The matrix material should be biodegradable.

It is either a polymer or a protein .

Ex: Albumin ,Egg albumin , Bovine serum albumin.

Thermo setting polymers include poly urethanes, phenol/formaldehyde and

urea formaldehyde resins.

HYDROPHOBIC LIQUID PHASE

The flash point of the oil should be higher than the denaturation temparature of

the protein.

If solvents are used the boiling point should be higher than the denaturation

temparature.

Ex: cotton seed oil, Corn seed oil, Silicon oil.

SURFACTANTS

• Used to decrease the hydrophobicity of matrix material to mitigate

agglomeration of microdroplets,

• Disperse the carriers more evenly

Eg: Sorbitan esters, polyoxyethylene ethers, Glycerol esters, Sorbitan

sesquiolate

MAGNETS

Iron oxide such as magnetite (Fe3O4) or magnemite ( ץ-Fe2O3) are more stable

against oxidation and are preferentially used as core material instead of iron.

Estoper M particles are super paramagnetic and used in immuno assays,cell

separation and nucleic acid purification.

Ex: Silica magnet particles

Cellulose magnetic particles

Ferro fluids

LIGANDS

Incorporated in order to prevent the RES clearance.

Ex:Avidin, Biotin, Streptavidin, Lectins.

PREPARATION OF MAGNETIC MICROSPHERES

The magnetic microspheres are prepared by :

1)Heat denaturation

2)Chemical cross linking:

also prepared by stabilising the albumin matrix with aldehyde cross linking agent.

Ex: glutaraldehyde.

These have been solubilized in organic phase.

Emulsion is homogenized by sonication method for 1min at 100W at 27°c.

Sonifier with a 0.635 cm titanium probe inside a circulating attachment chamber is used.

Preparation involves emulsification fOllowed by heat denaturation

matrix stabilization 1)Heat denaturation

2)Chemical crosslinking

Results in the formation of non-cross linked microspheres.

Emulsion is homogenized by sonication

Emusified with 30ml of cotton seed oil by the use of surfactant

Aqueous solution of human serum albumin+ drug+ magnetite

In the heat denaturation process stabilization varied with temperature and time.

This procedure generates small non cross linked microspheres.

Matrix stabilization is subsequently achieved by :

Heat denaturation at a temperature between 100-165°c

Treatment with oil soluble reagents such as 0.2M 2,3-butane dione or glutaraldehyde.

In the case of chemical cross linkers denaturation varies with exposure time

Oil and the cross linking agents are removed by multiple diethyl ether washings.

STORAGE Magnetic micro spheres are stored in the powder form

These are stored at a temperature of 4°c.

CHARACTERIZATION OF MAGNETIC MICRO SPHERESDETERMINATION OF DRUG LOADING AND ENTRAPMENT EFFICIENCY

Drug loaded microspheres are digested with suitable reagent at room

temperature and kept for 24 hrs to precipitate the protein .The digested

homogenate is centrifuged and supernatant is analyzed for drug content by

measuring its absorbance. The drug loading in microspheres is estimated by

using the formula .

L = QM/WM*100

L = %Drug loading of micro spheres

QM= Quantity of drug present

WM= Weight of microspheres

DETERMENATION OF MAGNETITE CONTENT

The magnetite content in microspheres is estimated quantitatively by

hydrolyzing an aliquot of the microspheres in concentrated HCl and the resultant

hydrolysate for iron is determined by atomic absorption spectroscopy at 248nm .It

has been demonstrated that microspheres containing magnetite of 20-28%w/w

are effectively targeted by at the site by using the magnet of 5000-8000G.

PARTICLE SIZE ANALYSIS:

1) scanning electron microscopy

2) Laser diffraction

3) Zeta sizer

4) Confocal laser scanning microscopy

MAGNETIC RESPONSIVITY MEASUREMENT Mille pore pumps air in to the flask containing normal saline .

It results in the flow of saline into the tube exposed to an electro magnet.

The pump pressure maintained was 0.5 cm/s resembles the rate blood flow in the

capillaries.

1ml microspheres dispersed in saline containing tween-80 was injected in to the

injection site.

8000G of magnetic field was applied for 15min a,samples collected every minute.

samples analysed by UV-Visible specrophotometer

at the גmax of the drug.

Higher the absorbance –greater the amount of drug

lower the magnetic retention in the tube –

lower the magnetic responsivity .

MEASUREMENT OF ELECTROPHORETIC MOBILITY BY USING OPTICAL MICROSCOPY

Measurement of electrophoretic mobility

helps in the prediction of magnetic

microspheres behaviour in the

patients blood circulation.

ϰ = magnetic susceptibility.

Vm =volume of the magnetic component

The movement of magnetic microspheres

is determined by the Magnetic propertites of

the particle, magnetic component volume,

magnetic susceptibility ,viscosity,diameter.

A piece of acrylic was placed on the micro scope table.

Glass capillary was filled with microsphere suspension using 1ml syringe.

During filling the magnet was placed18mm away from the capillary

The microscope was manually focused ,the colour video camera connected to

computer ,displays a clear picture.

The magnet was now closely moved to capillary image acquisition was started.

The images were saved per sample at an interval of 10 frame per second.

The difference in two successive images results in differential picture of only the

moving particles.

From the pictures individual parameters for each moving microsphere were

automatically determined.

Limitation

Particle diameter lessthan1.3µm can’t be detected.

DENSITY DETERMENATION Measured by using multi volume Pycnometer.

Accurately weighed sample was placed In multivolume pycnometer.

Helium was introduced at a constant pressure into the chamber.

Allowed to expand this expansion results in decrease in pressure within the

chamber

Two consecutive readings of reduction in pressure were noted from this the volume

and density of the carrier was determined.

SURFACE HYDROPHOBICITY:

Determined by measuring angle of contact.

The surface hydrophobicity of microspheres has an important influence on the

interaction of colloidal particles with the biological environment .

It regulates the extent and type of hydrophobic interactions of microparticles with

blood components.

INVITRO RELEASE STUDIES

Same as the normal dissolution procedure. Done by using USP paddle apparatus .

Initial release is due to the release of surface drug and small microspheres with

increased surface area & the presence of water soluble drugs.

The drug partition coefficient effects the release rate .

Higher the partition coefficient –faster the release because it results in the

migration of drug to the outer organic phase, during preparation

IN VIVO RELEASE STUDIES :

Micro spheres are tested in vivo to assess the validity of drug targeting

concept .The subcutaneous tissue in the tail of rats is chosen as the initial target

site for microsphere localization.

The ventral caudal artery is selected for microsphere infusion as it supplies the

majority of the blood to tail.

APPLICATIONS

1).Hyperthermic treatment of cancer

Hyperthermia involves heating and destroying the target tissue between temperature 42-

46°C.

20-30µm of ferromagnetic microspheres are used to induce hyperthermia in cancers, for

tumors located deep inside the body.

2.DETECTION OF GLYCATED HAEMOGLOBIN

The determination of glycated haemoglobin using PVA magnetic microspheres

It is an alternative to currently used methods

Used in blood sugar diagnosis.

Preparation of magnetic microspheres encapsulated with diclofenac sodiuM

Diclofenac has short half life ,it should be given frequently to maintain

therapeutic activity and is often associated with GIT bleeding ,gastric

ulcers ,blood dyscrasias and anaphylaxis.

To over come this toxicity and prolong the therapeutic effect at the target site

magnetic albumin microspheres of diclofenac were prepared.

Using magnetic field to repair damaged retinas: Conventional way to repair damaged retinas.

Inject silicone fluid or a special gas directly in to the eye to push the retina

back into place.

This makes the repair easier and more precise by allowing the fluid to be

removed to the areas of the eye that are hard to reach.

Magnetic immuno assay of acute myocardial infARction:

Magnetic immunoassay was developed to test the 2 markers of AMI

Myoglobin

Fatty acid binding protein

These markers shows elevated serum levels soon after infarction .

Immuno assay follows a standard solid phase ELISA consisting of the formation of

a complex /sandwich by attaching two different Ab to different epitopes.

Albumin magnetic micro spheres are prepared and coupled with avidin.

Ab are monoclonal mouse anti-human cardiac myoglobin.

Enzyme is alkaline phosphate coupled with streptavidin.

Biotin serves as abridging link between microspheres -antibody – alkaline phosphate.

Results in the formation of complex.

These complexes are separated by using external magnetic field.

To this add chemical reagent Nitro-phenol phosphate –produces an yellow substrate.

Intensity of the colour was measured by UV visible spectro photometer at 450nm.

Higher the intensity – greater the myoglobin concentration.

detox regime :

magnetic microspheres also helps to treat after a poison gas attack.

The poison process involves injection of magnetic particles that had been

functionalized to bind with the foreign toxin.

An external magnetic field would then be used to draw the toxin tagged particles

out of the body.

Efficient detoxification will require particles with a reasonably high magnetic

moment that can be pulled together with any attached toxin molecules across a

magnetic field gradient.

Cell separatiOn:

Polymeric microspheres conjugated to antibodies and lectins have been used

previously as cell surface markers for the detection and localization of antigens and

lectin receptors using scanning electron microscopy (SEM) .

A new, more versatile cell surface probe consisting of iron-containing polymeric

microspheres tagged with fluorescent dyes and chemically coupled to antibodies or

lectins.

Magnetic and fluorescent properties of microspheres have been utilised in the

magnetic separation of red blood cells (RBC) and lymphoid cells.

Magnetic control of pharmaco kinetic parameters and drug release

The magnetite was embedded in to the drug filled polymer matrix and showed that

they activate or increase the release of drug from polymer by moving a magnet

over it or by applying oscillating magnet The micro movement within the crack

produce a micro crack and thus made the influx of liquid , dissolution and efflux of

the drug is possible.

USE OF MECHANICAL PROPERTIES OF MAGNETITE IN

THERAPY:

This is possible by filling an magnetic component in to the capsule or tablet, speed

of travel can be slow down at specific position by an external magnet ,thus

changing the drug absorption and increases the drug levels in blood.

OTHER APPLICATIONSDetermination of trace hydrazine by differential pulse voltametry

using magnetic microspheres.

Pulsed delivery of insulin in diabetic patients.

Used to deliver therapeutic radio isotopes.

Delivery of fibrinolytic agents in the treatment of deep venous

thromobosis and pulmonary embolism.

Magnetism has application in numerous fields like

Diagnostics,

Tumour targeting

Molecular biology

Cell isolation

Cell purification

Radioimmunoassay

Detection of immunoglobulin (Ig) receptors

wheat germ agglutinin (WGA) receptors on lymphocytes

by SEM and fluorescent microscopy..

CONCLUSION:Magnetic micro carriers have been investigated for targeted drug delivery

especially magnetic targeted chemotherapy due to their better tumor targeting,

therapeutic efficacy, lower toxicity and flexibility .

In spite of certain drawbacks, such as strong magnetic field requires for the

ferro fluid and deposition of magnetite the magnetic microcarriers still play an

important role in the selective targeting, and the controlled delivery of various

drugs.

It is a challenging area for future research in the drug targeting so more

researches, long term toxicity study, and characterization will ensure the

improvement of magnetic drug delivery system.

The future holds lot of promises in magnetic micro carriers and by further study

this will be developed as novel and efficient approach for  targeted drug delivery

system.

References Methods of dug delivery ,International encyclopedia of pharmacology and

therapeutics section 120 by G.M. Ihler PG.NO-39-56. Characterization of magnetic particles and their magneto phoretic mobility using

a digital microscopy by u.o. hafell,european cells and materials, vol-3 suplliment 2 ,2004,pg.n-24-27.

,”magnetically modulated drug delivery “, targeted and controlled drug delivery

by S.p.vyas and khar,1st edition ,2002,pg.no-417-458.

Microspheres technology and applications “, Encyclopedia of pharmaceutical

technology, 10th edition ,pg.no – 1-29.

,” magnetically modulated therapeutic systems”, international journal of

pharmaceutics, U.O. Hafel , 277(2004) pg.n :19-24. www.Magnetic magzine.com

www.magnetic microspheres.com

www.pharmainfo net.com

www.materials today.com www.wikipedia.com

THANK U